BofA Securities lifts Ambev S.A. [ABEV] price estimate. Who else is bullish?

Related

Ambev S.A. [NYSE: ABEV] stock went on a downward path that fall over -2.86% on Monday, amounting to a one-week price decrease of less than -0.73%. The company report on May 6, 2021 that Ambev SA to Host Earnings Call.

Ambev SA (FRA:AMNA) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 11:30 AM Eastern Time.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/event/presentation/77479.

Over the last 12 months, ABEV stock dropped by -6.25%. The one-year Ambev S.A. stock forecast points to a potential upside of 22.51. The average equity rating for ABEV stock is currently 3.20, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $42.80 billion, with 15.74 billion shares outstanding and 4.40 billion shares in the current float. Compared to the average trading volume of 23.64M shares, ABEV stock reached a trading volume of 23909079 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Ambev S.A. [ABEV]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ABEV shares is $3.51 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABEV stock is a recommendation set at 3.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

BofA Securities have made an estimate for Ambev S.A. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on November 03, 2021. While these analysts kept the previous recommendation, Barclays dropped their target price from $4 to $3.50. The new note on the price target was released on October 06, 2021, representing the official price target for Ambev S.A. stock. Previously, the target price had yet another raise to $2.60, while Goldman analysts kept a Sell rating on ABEV stock.

The Average True Range (ATR) for Ambev S.A. is set at 0.07, with the Price to Sales ratio for ABEV stock in the period of the last 12 months amounting to 0.69. The Price to Book ratio for the last quarter was 0.52.

ABEV Stock Performance Analysis:

Ambev S.A. [ABEV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.73. With this latest performance, ABEV shares dropped by -0.24% in over the last four-week period, additionally sinking by -16.57% over the last 6 months – not to mention a drop of -6.25% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ABEV stock in for the last two-week period is set at 45.37, with the RSI for the last a single of trading hit 41.92, and the three-weeks RSI is set at 42.47 for Ambev S.A. [ABEV]. The present Moving Average for the last 50 days of trading for this stock 2.90, while it was recorded at 2.74 for the last single week of trading, and 3.08 for the last 200 days.

Insight into Ambev S.A. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Ambev S.A. [ABEV] shares currently have an operating margin of +23.42 and a Gross Margin at +49.90. Ambev S.A.’s Net Margin is presently recorded at +19.49.

Return on Total Capital for ABEV is now 18.79, given the latest momentum, and Return on Invested Capital for the company is 16.31. Return on Equity for this stock inclined to 16.85, with Return on Assets sitting at 9.77. When it comes to the capital structure of this company, Ambev S.A. [ABEV] has a Total Debt to Total Equity ratio set at 6.49. Additionally, ABEV Total Debt to Total Capital is recorded at 6.10, with Total Debt to Total Assets ending up at 3.72. Long-Term Debt to Equity for the company is recorded at 2.78, with the Long-Term Debt to Total Capital now at 2.61.

Reflecting on the efficiency of the workforce at the company, Ambev S.A. [ABEV] managed to generate an average of $227,588 per employee. Receivables Turnover for the company is 7.22 with a Total Asset Turnover recorded at a value of 0.50.

ABEV Stock EPS

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ABEV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Ambev S.A. go to 7.40%.

>> 7 Top Picks for the Post-Pandemic Economy <<

Ambev S.A. [ABEV] Insider Position Details

Positions in Ambev S.A. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 128 institutional holders increased their position in Ambev S.A. [NYSE:ABEV] by around 101,579,622 shares. Additionally, 113 investors decreased positions by around 188,984,275 shares, while 62 investors held positions by with 1,075,758,319 shares. The mentioned changes placed institutional holdings at 1,366,322,216 shares, according to the latest SEC report filing. ABEV stock had 31 new institutional investments in for a total of 9,967,393 shares, while 33 institutional investors sold positions of 87,441,428 shares during the same period.